Much has been done since revealing this week of the new Apple Watch, which sports an abundance of health-specific features like its fall detection and the ability to take an electrocardiogram.
Buried in this skeptical piece from Quartz who claims that the new clothing feature is not so impressive, we also look at study results that seem a little incongruous to include in a piece that is doubtful about the clock. To get FDA clearance for inclusion and marketing of the clock's ECG features, Apple and Stanford University conducted a survey of just under 600 people, where the results were sent to the FDA for review.
According to Kvarts : Half of the study friends were healthy, while the other half had atrial fibrillation ̵
Cardiologists, according to Quartz reported, could read 90% of the total readings, although about 10% of them were unreadable. So at a level that definitely sounds promising for a product that Apple tries to position as "an intelligent guardian for your health."
So why are some people skeptical about some of the most promising aspects of the clock? Andrew Moore, a medical officer at Oregon Health and Science University told Quartz the technology at the time is "rudimentary" compared to what you would get in a hospital setting. That leaves someone who wants to respond – well, of course, the $ 399 clock (preorders that went live today), does not compare with the much more robust treatment and diagnosis that happens in a hospital setting.
We have already written about This in an earlier post, but the FDA gave Apple the approvals it needed for the clock, provided it emphasizes that any readings should be seen as a guide that you want to have a doctor to look at . That the readings you receive on your watch should not be considered a final medical diagnosis.
Washington Post reviewed this and noted that "heart rhythms naturally vary, which means it is likely that Apple Watch or any cardiac monitoring can signal a problem when there is no – and send someone who drives the doctor for no reason. "
The new Apple Watchen falls into an FDA category for" low to moderate risk "units. The risk here is the error message of the user's heart rate, which is not as likely to be fatal as you would like to see with a sub-device in a higher risk category. To get FDA clearance, Apple had to show that the device was safe and functioning. As you can see from the study results, there were requirements that the company easily met.